US Patent Issued to Novartis on Jan. 27 for "Treatment of autoimmune disease in a patient receiving additionally a beta-blocker" (Swiss, Indian, British, Singaporean, French Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,340, issued on Jan. 27, was assigned to Novartis AG (Basel, Switzerland).

"Treatment of autoimmune disease in a patient receiving additionally a beta-blocker" was invented by Eric Legangneux (Levallois-Perret, France), Alexandros Sagkriotis (Basel, Switzerland), Pierre Jordaan (Bettingen, Switzerland), Florine Polus (Basel, Switzerland), Alan John Camm (London), Shibadas Biswal (Nucleos North Tower, Singapore), Parasar Pal (Rangareddy, India), Uday Kiran Veldandi (Rangareddy, India), Atul Keshav Pawar (Navi Mumbai, India), Vassilios Aslanis (Basel, Switzerland) and Kasra Shakeri-Nejad (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office:...